Breaking News Instant updates and real-time market news.

KALA

Kala Pharmaceuticals

$12.64

0.36 (2.93%)

04:55
07/24/18
07/24
04:55
07/24/18
04:55

Kala Pharmaceuticals management to meet with JPMorgan

Meeting to be held in New York on July 24 hosted by JPMorgan.

  • 24

    Jul

  • 24

    Aug

KALA Kala Pharmaceuticals
$12.64

0.36 (2.93%)

01/05/18
WELS
01/05/18
NO CHANGE
WELS
Outperform
Kala dry eye trial results mixed but positive, says Wells Fargo
After Kala Pharmaceuticals reported that KPI-121 demonstrated statistically significant improvements in the primary sign and symptom endpoints in one Phase 3 trial but missed for the primary symptom endpoint in another trial, Wells Fargo analyst David Maris said the mixed data "complicates things" but still show a positive drug profile for KPI-121. He would expect the shares to be down on this data, but also believes some of the risk seems to have been in expectations given the stock having been down recently. Maris keeps an Outperform rating on Kala shares, which are down 24% in morning trading.
01/25/18
WELS
01/25/18
NO CHANGE
Target $19
WELS
Outperform
Kala Pharmaceuticals price target lowered to $19 from $24 at Wells Fargo
Wells Fargo analyst David Maris lowered his price target for Kala Pharmaceuticals to $19 from $24 on valuation after the shares dropped following mixed results from the two pivotal Phase III trials of its dry eye treatment, KPI-121. The analyst believes Kala's shares have the opportunity to outperform as investors shift their near-term focus to the company's post-surgical ocular steroid which has an August 2018 PDUFA. He reiterates an Outperform rating on the stock.
06/19/18
WELS
06/19/18
NO CHANGE
Target $19
WELS
Outperform
Kala Pharma's KPI-121 update suggests faster market entry, Wells Fargo says
Wells Fargo analyst David Maris kept his Outperform rating and $19 price target on Kala Pharmaceuticals, saying its announced plans to submit a new drug application for KPI-121 to the FDA in the second half of the year may expedite its market entry. The analyst adds that the most likely scenario is for the FDA to accept the company's NDA for review but ultimately consider the Stride 3 data and issue a Complete Response Letter for an additional study, which will likely lead to a class 2 resubmission and a shortened 6-month review period. Maris contends that it is also possible that the FDA "accepts Kala's NDA, finds the existing data to be sufficient, and approves KPI-121 0.25% in its first review cycle, leading to a late-2019 or early 2020 commercialization.
07/23/18
HCWC
07/23/18
INITIATION
Target $35
HCWC
Buy
Kala Pharmaceuticals initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Raghuram Selvaraju started Kala Pharmaceuticals with a Buy rating and $35 price target. The current valuation provides an "intriguing entry point" for investors ahead of the "risk-mitigated catalyst," the potential approval of Inveltys, Selvaraju tells investors in a research note. The analyst has "high confidence" that the drug should be approved in a "timely manner."

TODAY'S FREE FLY STORIES

GIS

General Mills

$53.74

0.08 (0.15%)

, PAYX

Paychex

$85.15

-1.02 (-1.18%)

13:38
06/25/19
06/25
13:38
06/25/19
13:38
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

GIS

General Mills

$53.74

0.08 (0.15%)

PAYX

Paychex

$85.15

-1.02 (-1.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 26

    Jun

  • 09

    Jul

  • 10

    Jul

  • 11

    Jul

FDX

FedEx

$156.37

-4.51 (-2.80%)

, MU

Micron

$33.30

0.12 (0.36%)

13:38
06/25/19
06/25
13:38
06/25/19
13:38
Earnings
Notable companies reporting after market close »

Notable companies…

FDX

FedEx

$156.37

-4.51 (-2.80%)

MU

Micron

$33.30

0.12 (0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 25

    Jun

  • 09

    Jul

  • 30

    Jul

  • 31

    Jul

  • 13

    Nov

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$291.98

-1.66 (-0.57%)

13:37
06/25/19
06/25
13:37
06/25/19
13:37
Periodicals
Presidents Trump, Xi to meet Saturday in Japan, Reuters says »

Presidents Trump and Xi…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$291.98

-1.66 (-0.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSM

TSMC

$39.05

-0.93 (-2.33%)

13:35
06/25/19
06/25
13:35
06/25/19
13:35
Options
Taiwan Semi put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UPS

UPS

$97.22

-2.47 (-2.48%)

, FDX

FedEx

$156.36

-4.52 (-2.81%)

13:28
06/25/19
06/25
13:28
06/25/19
13:28
Periodicals
UPS says won't join FedEx's suit against U.S., Reuters says »

UPS (UPS) said it does…

UPS

UPS

$97.22

-2.47 (-2.48%)

FDX

FedEx

$156.36

-4.52 (-2.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 25

    Jun

  • 26

    Jun

  • 24

    Jul

  • 30

    Jul

  • 31

    Jul

  • 13

    Nov

EOLS

Evolus

$14.26

0.57 (4.16%)

, AGN

Allergan

$164.07

34.42 (26.55%)

13:26
06/25/19
06/25
13:26
06/25/19
13:26
Recommendations
Evolus, Allergan, AbbVie, Revance, Aerie Pharmaceuticals, TherapeuticsMD, Kala Pharmaceuticals analyst commentary  »

Evolus can benefit from…

EOLS

Evolus

$14.26

0.57 (4.16%)

AGN

Allergan

$164.07

34.42 (26.55%)

ABBV

AbbVie

$66.52

-11.89 (-15.16%)

RVNC

Revance

$12.15

0.59 (5.10%)

AERI

Aerie Pharmaceuticals

$30.34

0.13 (0.43%)

TXMD

TherapeuticsMD

$2.58

0.06 (2.38%)

KALA

Kala Pharmaceuticals

$5.78

0.2 (3.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 25

    Jun

  • 10

    Jul

  • 10

    Jul

  • 11

    Jul

  • 11

    Jul

  • 31

    Jul

  • 01

    Aug

  • 15

    Aug

  • 16

    Sep

TDG

TransDigm

$490.64

-0.47 (-0.10%)

13:25
06/25/19
06/25
13:25
06/25/19
13:25
Hot Stocks
DoD: TransDigm 'negotiating excessive profits' on contracts for spare parts »

The Department of Defense…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSN

Tyson Foods

$82.69

1.85 (2.29%)

13:25
06/25/19
06/25
13:25
06/25/19
13:25
Options
Tyson Foods call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:25
06/25/19
06/25
13:25
06/25/19
13:25
General news
Fed Chair Powell repeated the phrase from the FOMC that the Fed is "closely monitoring »

Fed Chair Powell repeated…

IBKR

Interactive Brokers

$52.66

0.21 (0.40%)

, ETFC

E-Trade

$44.43

-0.14 (-0.31%)

13:25
06/25/19
06/25
13:25
06/25/19
13:25
Conference/Events
Sandler O'Neill financial analyst to hold an analyst/industry conference call »

Financial Analyst Repetto…

IBKR

Interactive Brokers

$52.66

0.21 (0.40%)

ETFC

E-Trade

$44.43

-0.14 (-0.31%)

SCHW

Charles Schwab

$39.22

0.07 (0.18%)

AMTD

TD Ameritrade

$48.32

0.23 (0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 23

    Jul

  • 06

    Aug

  • 27

    Oct

13:20
06/25/19
06/25
13:20
06/25/19
13:20
General news
FX Action: The DXY rallied »

FX Action: The DXY…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
06/25/19
06/25
13:17
06/25/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
06/25/19
06/25
13:16
06/25/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HUYA

Huya

$23.90

-1.52 (-5.98%)

13:15
06/25/19
06/25
13:15
06/25/19
13:15
Options
HUYA put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:15
06/25/19
06/25
13:15
06/25/19
13:15
General news
Treasury's $40 B 2-year auction was mixed as a confluence of factors impacted »

Treasury's $40 B…

ASOMY

Asos

$0.00

(0.00%)

13:11
06/25/19
06/25
13:11
06/25/19
13:11
Downgrade
Asos rating change  »

Asos downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$33.46

0.28 (0.84%)

13:08
06/25/19
06/25
13:08
06/25/19
13:08
On The Fly
Fly Intel: What to watch in Micron's earnings report »

Micron (MU) is scheduled…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 09

    Jul

13:08
06/25/19
06/25
13:08
06/25/19
13:08
General news
2-Yr Note Auction Coupon Rate data reported »

2-Yr Note Auction Coupon…

13:07
06/25/19
06/25
13:07
06/25/19
13:07
General news
2-Yr Note Auction Total Amount data reported »

2-Yr Note Auction Total…

MDR

McDermott

$8.82

0.6 (7.30%)

13:05
06/25/19
06/25
13:05
06/25/19
13:05
Options
McDermott call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$56.48

-0.24 (-0.42%)

13:03
06/25/19
06/25
13:03
06/25/19
13:03
Hot Stocks
Oracle announces 'simplified' analytics product offering »

Oracle said in a press…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLF

Herbalife Nutrition

$43.03

0.82 (1.94%)

12:55
06/25/19
06/25
12:55
06/25/19
12:55
Options
Herbalife put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:55
06/25/19
06/25
12:55
06/25/19
12:55
General news
Fed dove, and dissenter Bullard doesn't believe a 50 bp easing is necessary right now »

Fed dove, and dissenter…

AGN

Allergan

$163.79

34.14 (26.33%)

, ABBV

AbbVie

$66.51

-11.905 (-15.18%)

12:50
06/25/19
06/25
12:50
06/25/19
12:50
Upgrade
Allergan, AbbVie rating change at Barclays »

Allergan upgraded to…

AGN

Allergan

$163.79

34.14 (26.33%)

ABBV

AbbVie

$66.51

-11.905 (-15.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 16

    Sep

AG

First Majestic

$7.98

-0.04 (-0.50%)

12:45
06/25/19
06/25
12:45
06/25/19
12:45
Options
First Majestic call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.